StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.88−0.08 (-8.24%)

Close on Nov 16, 2026Market cap $13.93MP/E –Yield –

Allarity Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Allarity Therapeutics's enterprise value was $18.76M on Nov 11, 2026, against $4.53M a year earlier. Over the last 5 years it ranged from -$15.47M to $2.01T, with a median of $26.21M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.76M+3612.3%
2025Dec 31, 2025$505.38K–
2024Dec 31, 2024-$15.27M-101.1%
2023Dec 29, 2023$1.38B-98.1%
2022Dec 30, 2022$72.35B-96.4%
2021Dec 31, 2021$2.01T–

More Allarity Therapeutics figures

See a number that looks wrong?